# A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome

> **NCT02137421** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 20 (actual)

## Conditions studied

- Metabolic Syndrome
- Coronary Artery Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Resveratrol (3, 4´, 5 trihydroxystilbene)

## Key facts

- **NCT ID:** NCT02137421
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137421, "A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02137421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*